Rest of Asia
Logo
 

Covid-19: Russia agrees to produce coronavirus vaccine Sputnik V in India

Reuters/Moscow
Filed on November 27, 2020 | Last updated on November 27, 2020 at 11.17 am
Reuters

Phase II-III trials are ongoing in India.

Russia’s sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against Covid-19, according to a statement on the Sputnik V Twitter account on Friday.

Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plan to start production of Sputnik V in India at the beginning of 2021, the statement said.

Phase II-III trials are ongoing in India, the statement said. Drugmaker Dr Reddy’s Laboratories Ltd has said it expects late-stage trials to be completed by as early as March 2021.





ERROR: Macro /ads/dfp-ad-article-new is missing!
MORE FROM World
MORE FROM Khaleej Times
CurrentRequestUnmodified: /apps/pbcs.dll/article?avis=KT&date=20210119&category=ARTICLE&lopenr=210118945&Ref=AR&profile=1031 macro_action: article, macro_profile: , macro_adspot:
 
 
 
 
KT App Download
khaleejtimes app

All new KT app
is available
for download:

khaleejtimes - android khaleejtimes - ios khaleejtimes - HUAWEI AppGallery